A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2, PHASE3

מצבים רפואיים

Heterozygous Familial Hypercholesterolemia (HeFH)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Nemours/Alfred I. duPont Hospital for Children ( Site 0001), Wilmington, Delaware, United States

    Study coordinator · 302-651-6600
  • Children's National Medical Center ( Site 0015), Washington D.C., District of Columbia, United States

    Study coordinator · 202-476-5000
  • Excel Medical Clinical Trials ( Site 0008), Boca Raton, Florida, United States

    Study coordinator · 561-529-4356
  • Children's Healthcare of Atlanta Cardiology ( Site 0026), Atlanta, Georgia, United States

    Study coordinator · 404-256-2593
  • Cincinnati Children's Hospital Medical Center ( Site 0016), Cincinnati, Ohio, United States

    Study coordinator · 513-636-3200
  • West Virginia University ( Site 0013), Morgantown, West Virginia, United States

    Study coordinator · 304-598-4000
  • Monash Children s Hospital ( Site 1603), Clayton, Victoria, Australia

    Study coordinator · +61385723000
  • UZ Antwerpen ( Site 0601), Edegem, Antwerpen, Belgium

    Study coordinator · +323 821 32 51
  • Universidade Federal Do Ceara ( Site 0201), Fortaleza, Ceará, Brazil

    Study coordinator · +558533668590
  • Incor - Instituto do Coracao ( Site 0200), São Paulo, Brazil

    Study coordinator · +551126615450
  • Explora Salud ( Site 0304), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56944213579
  • Pontificia Universidad Catolica de Chile ( Site 0300), Santiago, Region M. de Santiago, Chile

    Study coordinator · 56934331806
  • Beijing Anzhen Hospital. Capital Medical University ( Site 1917), Beijing, Beijing Municipality, China

    Study coordinator · 010-64412431
  • Shanghai Children's Medical Center ( Site 1918), Shanghai, Shanghai Municipality, China

    Study coordinator · 021-38626161
  • The Children's Hospital of Zhejiang University School of Medicine ( Site 1905), Hangzhou, Zhejiang, China

    Study coordinator · 0571-86036545
  • Clinica de la Costa S.A.S. ( Site 0400), Barranquilla, Atlántico, Colombia

    Study coordinator · +57 3133894240
  • Oncomédica S.A.S ( Site 0401), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +57 3135342052
  • Fundación Cardiovascular de Colombia ( Site 0402), Piedecuesta, Santander Department, Colombia

    Study coordinator · +573203400438
  • Fundacion Valle del Lili ( Site 0403), Cali, Valle del Cauca Department, Colombia

    Study coordinator · +573166237452
  • New Childrens Hospital ( Site 0800), Helsinki, Uusimaa, Finland

    Study coordinator · +358 9 4711
  • Universitaetsklinikum Freiburg ( Site 2203), Freiburg im Breisgau, Baden-Wurttemberg, Germany

    Study coordinator · +49 761 270 - 43000
  • Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" ( Site 0501), Monterrey, Nuevo León, Mexico

    Study coordinator · +52 8183338623
  • Centro de Investigacion Clinica de Oaxaca ( Site 0505), Oaxaca City, Oaxaca, Mexico

    Study coordinator · +52 9516035559
  • INVECORDIS S.C. ( Site 0503), Huixquilucan, Mexico

    Study coordinator · +525552469710
  • Amsterdam UMC, locatie AMC ( Site 1000), Amsterdam, North Holland, Netherlands

    Study coordinator · +31205666360
  • New Zealand Clinical Research (Christchurch) ( Site 1700), Christchurch, Canterbury, New Zealand

    Study coordinator · NZCR +6433729477
  • National University Hospital-Paediatrics ( Site 1800), Singapore, Central Singapore, Singapore

    Study coordinator · +6567795555
  • Hospital Universitario Central de Asturias ( Site 1303), Oviedo, Asturias, Principado de, Spain

    Study coordinator · +34985108000
  • Hospital Clinico Universitario de Santiago de Compostela ( Site 1300), Santiago de Compostela, La Coruna, Spain

    Study coordinator · +34981951108
  • COMPLEJO HOSPITALARIO DE NAVARRA ( Site 1302), Pamplona, Navarre, Spain

    Study coordinator · +34660021505
  • Birmingham Childrens Hospital ( Site 1501), Birmingham, United Kingdom

    Study coordinator · +441213338504
  • Sheffield Childrens Hospital ( Site 1503), Sheffield, United Kingdom

    Study coordinator · +441142717000
  • Southampton General Hospital ( Site 1502), Southampton, United Kingdom

    Study coordinator · +442381204989
מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC